Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
AnaptysBio Inc banner

AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 52.415 USD 0.59%
Market Cap: $1.5B
Write Note Create Alert Ask AI

Wall St Price Targets

ANAB Price Targets Summary
AnaptysBio Inc

Wall Street analysts forecast ANAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANAB is 90.576 USD with a low forecast of 75.75 USD and a high forecast of 147 USD.

ANAB Lowest Forecast
Wall Street Target
$75.75
45% Upside
ANAB Average Forecast
Wall Street Target
$90.576
73% Upside
ANAB Highest Forecast
Wall Street Target
$147
180% Upside
Lowest Forecast
Price Target
75.75 USD
45% Upside
Average Forecast
Price Target
90.576 USD
73% Upside
Highest Forecast
Price Target
147 USD
180% Upside
AnaptysBio Inc Competitors:
Price Targets
EOLS
Evolus Inc
148% Upside
R
RCR
RL Commercial REIT Inc
19% Upside
EOLS
Evolus Inc
148% Upside
R
RCR
RL Commercial REIT Inc
19% Upside

Revenue
Forecast

28% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
28% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

23% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
23% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 11 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 8 years is 39%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

What are analyst estimates?

Continue ANAB Research

Summary
ANAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANAB stock valuation using valuation multiples.
Wall St Estimates
ANAB price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other AnaptysBio Inc listings:
F • EUR
AN6
 LSE • USD
0HFQ
 NASDAQ • USD
ANABV
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ANAB's stock price target?
Price Target
90.576 USD

According to Wall Street analysts, the average 1-year price target for ANAB is 90.576 USD with a low forecast of 75.75 USD and a high forecast of 147 USD.

What is the Revenue forecast for AnaptysBio Inc?
Projected CAGR
12%

Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 12%.

What is the Operating Income forecast for AnaptysBio Inc?
Projected CAGR
39%

Over the last 11 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 8 years is 39%.

Back to Top
ALPHA SPREAD
Follow us
Join 350,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett